VulnerabilityModified
CVE-2018-5439
A Command Injection issue was discovered in Nortek Linear eMerge E3 series Versions V0.32-07e and prior.
CRITICAL 9.8EPSS 4.21%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (4.21%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
A Command Injection issue was discovered in Nortek Linear eMerge E3 series Versions V0.32-07e and prior. A remote attacker may be able to execute arbitrary code on a target machine with elevated privileges.
- CVSS 3.0
- 9.8 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 4.21% probability · 90th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-77
- Affected
- nortekcontrol/emerge e3 firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://ics-cert.us-cert.gov/advisories/ICSA-18-046-01Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSA-18-046-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.